IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $119,000 | +8.2% | 24,892 | +1.6% | 0.01% | +16.7% |
Q2 2022 | $110,000 | +61.8% | 24,500 | +70.8% | 0.01% | +50.0% |
Q1 2022 | $68,000 | -37.0% | 14,344 | -1.2% | 0.00% | -33.3% |
Q4 2021 | $108,000 | +27.1% | 14,524 | -2.7% | 0.01% | 0.0% |
Q3 2021 | $85,000 | -12.4% | 14,923 | +1.3% | 0.01% | -14.3% |
Q2 2021 | $97,000 | -61.5% | 14,730 | -52.6% | 0.01% | -68.2% |
Q1 2021 | $252,000 | +162.5% | 31,096 | +108.1% | 0.02% | +100.0% |
Q4 2020 | $96,000 | +74.5% | 14,941 | -2.4% | 0.01% | +57.1% |
Q3 2020 | $55,000 | -22.5% | 15,305 | -0.8% | 0.01% | -36.4% |
Q2 2020 | $71,000 | +20.3% | 15,434 | -11.4% | 0.01% | -8.3% |
Q1 2020 | $59,000 | +43.9% | 17,411 | +2.0% | 0.01% | +71.4% |
Q3 2019 | $41,000 | +5.1% | 17,066 | -4.8% | 0.01% | 0.0% |
Q2 2019 | $39,000 | -18.8% | 17,926 | +2.0% | 0.01% | -22.2% |
Q1 2019 | $48,000 | – | 17,578 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |